Seneca Biopharma Inc (SNCA)

0.8521 +0.00  +0.48% NASDAQ Aug 7, 20:00 USD

Seneca Biopharma Revenue (TTM):

0.0189M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (TTM) Chart

Export Data
Save Image
Print Image

Historical Revenue (TTM) Data

View and export this data going back to 2005. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 0.0189M
Dec. 31, 2019 0.0154M
Sept. 30, 2019 0.0154M
June 30, 2019 0.0154M
March 31, 2019 0.26M
Dec. 31, 2018 0.26M
Sept. 30, 2018 0.51M
June 30, 2018 0.51M
March 31, 2018 0.26M
Dec. 31, 2017 0.26M
Sept. 30, 2017 0.0162M
June 30, 2017 0.0162M
March 31, 2017 0.0162M
Dec. 31, 2016 0.0162M
Sept. 30, 2016 0.01M
June 30, 2016 0.01M
March 31, 2016 0.01M
Dec. 31, 2015 0.0104M
Sept. 30, 2015 0.0126M
June 30, 2015 0.0151M
March 31, 2015 0.0176M
Dec. 31, 2014 0.0188M
Sept. 30, 2014 0.0167M
June 30, 2014 0.0142M
March 31, 2014 0.0117M
   
Dec. 31, 2013 0.11M
Sept. 30, 2013 0.11M
June 30, 2013 0.2783M
March 31, 2013 0.354M
Dec. 31, 2012 0.4077M
Sept. 30, 2012 0.6924M
June 30, 2012 0.625M
March 31, 2012
Dec. 31, 2011
Sept. 30, 2011
June 30, 2011
March 31, 2011
Dec. 31, 2010
Sept. 30, 2010
June 30, 2010
March 31, 2010
Dec. 31, 2009
Sept. 30, 2009
June 30, 2009
March 31, 2009
Dec. 31, 2008
Sept. 30, 2008
June 30, 2008
March 31, 2008
Dec. 31, 2007

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Benchmarks

Benchmarks
Teligent Inc 60.22M
Arcturus Therapeutics Holdings Inc 19.08M
Titan Pharmaceuticals Inc 4.002M

Revenue (TTM) Range, Past 5 Years

Minimum 0.01M Mar 2016
Maximum 0.51M Jun 2018
Average 0.118M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.